NCT02442570View on ClinicalTrials.gov

A Study to Evaluate Safety and Efficacy of DC-TAB in Multiple Sclerosis

PHASE2CompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

September 30, 2012

Primary Completion Date

June 30, 2014

Study Completion Date

February 28, 2015

Conditions
Multiple Sclerosis
Interventions
BIOLOGICAL

recombinant human alpha B-crystallin

intravenous injections

OTHER

Placebo comparator

intravenous injection

Trial Locations (5)

1113

Sveti Naum Hospital, Sofia

1309

National Cardiology Hopsital, Sofia

1407

Tokuda Hospital Sofia, Sofia

1431

Aleksandrovska Hospital, Sofia

Military Medical Academy, Sofia

All Listed Sponsors
lead

Delta Crystallon BV

INDUSTRY

NCT02442570 - A Study to Evaluate Safety and Efficacy of DC-TAB in Multiple Sclerosis | Biotech Hunter | Biotech Hunter